STOCK TITAN

Travelers Compan SEC Filings

TRV NYSE

Welcome to our dedicated page for Travelers Compan SEC filings (Ticker: TRV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

This page provides access to U.S. Securities and Exchange Commission filings for The Travelers Companies, Inc. (NYSE: TRV), a property casualty insurer that offers auto, home and business coverage. Travelers’ filings give investors and analysts detailed information about its financial condition, capital structure, risk profile and governance.

Travelers uses current reports on Form 8-K to disclose material events and updates. For example, a Form 8-K filed on October 16, 2025, furnishes a press release and financial supplement reporting the company’s results for the quarter ended September 30, 2025. Another Form 8-K filed on July 24, 2025, describes an underwriting agreement for the issuance and sale of senior notes due 2035 and 2055, and confirms that Travelers’ common stock trades on the New York Stock Exchange under the symbol TRV.

In addition to 8-Ks, Travelers files annual reports on Form 10-K and quarterly reports on Form 10-Q, which contain segment information for Business Insurance, Bond & Specialty Insurance and Personal Insurance, as well as discussions of underwriting results, catastrophe losses, reserve development, net investment income and capital management. Proxy statements on Schedule 14A and beneficial ownership or insider transaction reports on forms such as Form 4 provide further insight into governance and executive and director share activity.

On Stock Titan, Travelers’ SEC filings are updated from the EDGAR system and presented with AI-powered summaries that highlight key points from lengthy documents. These summaries are designed to help users quickly understand the main drivers of performance, capital actions such as debt issuance, and other material disclosures without reading every page of the underlying filing.

Rhea-AI Summary

The Travelers Companies, Inc. reported a very strong first quarter of 2026, with net income rising to $1.71 billion, up from $395 million a year earlier. Diluted earnings per share jumped to $7.78 from $1.70, helped both by higher profits and fewer shares outstanding after repurchases.

Total revenues were $11.92 billion, slightly above last year as higher net investment income offset modestly lower earned premiums tied in part to the sale of Canadian operations. The consolidated combined ratio improved to 88.6% from 102.5%, driven by sharply lower catastrophe losses of $761 million versus $2.27 billion in 2025 and continued net favorable prior year reserve development of $413 million. Underlying results were partly offset by a somewhat higher expense ratio and softer margins in Business and Bond & Specialty Insurance.

Operating cash flow was strong at $2.20 billion, and investments totaled $102.98 billion, with 95% in fixed maturities and short-term securities. Shareholders’ equity stood at $31.99 billion despite $3.01 billion of net unrealized investment losses from higher interest rates. Travelers returned $2.22 billion to shareholders in the quarter, including $1.80 billion of common share repurchases and $238 million of dividends, while maintaining a debt-to-total capital ratio of 22.5%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.16%
Tags
quarterly report
-
Rhea-AI Summary

The Travelers Companies, Inc. reported an excellent first quarter of 2026 with net income of $1.711 billion, or $7.78 per diluted share, up sharply from $395 million, or $1.70 per share, a year earlier.

Core income rose to $1.696 billion, or $7.71 per diluted share, mainly due to much lower catastrophe losses and higher net investment income. The consolidated combined ratio improved to 88.6% from 102.5%, reflecting strong underwriting results across Business Insurance, Bond & Specialty Insurance, and Personal Insurance.

Return on equity reached 21.1%, with core return on equity at 19.7%. The company returned $2.223 billion of capital to shareholders, including $1.985 billion of share repurchases, and the Board approved a 14% increase in the regular quarterly dividend to $1.25 per share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.16%
Tags
current report
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report
Rhea-AI Summary

The Travelers Companies, Inc. is asking shareholders to vote at its May 20, 2026 annual meeting in Hartford, Connecticut. Items include electing eight directors, ratifying KPMG as independent auditor, a non-binding vote on executive pay, and amending the 2023 Stock Incentive Plan. Shareholders will also consider two shareholder proposals, which the Board recommends voting against.

The Board highlights that seven of eight nominees are independent and that all key committees (other than Executive) are fully independent. Compensation is structured as pay-for-performance, with most executive pay in performance-based cash and equity. The company describes extensive shareholder engagement, including outreach to holders of a large portion of outstanding shares, and emphasizes strong governance practices such as majority voting for directors, proxy access, no poison pill, and robust director and executive stock ownership requirements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

TRAVELERS COMPANIES, INC. director Elizabeth Robinson received a grant of 149.99 deferred common stock units at $291.68 per unit under the company’s non-employee director compensation plans. These deferred units are issued in lieu of cash compensation and will convert into shares of common stock on a one-for-one basis when distributed.

After this grant, Robinson holds a total of 12,382.571 deferred common stock units, including 45.955 units acquired on March 31, 2026 through dividend reinvestment features. Distribution of the underlying shares will occur at her election, either in a lump sum or in annual installments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Travelers Companies director Russell G. Golden received 158.560 deferred common stock units as compensation. The units were valued at $291.68 per share equivalent and are part of the Company’s Deferred Compensation Plan for Non-Employee Directors.

After this grant and related dividend reinvestment, Golden holds a total of 5,439.062 deferred common stock units, including 19.839 units acquired through the plans’ dividend reinvestment features. These units will convert into an equal number of Travelers common shares upon distribution, which can occur in a lump sum or annual installments at the director’s election.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Travelers Cos Inc/The amendment to a Schedule 13G shows The Vanguard Group reporting 0 shares and 0% beneficial ownership after an internal realignment. The filing states certain Vanguard subsidiaries will report holdings separately in reliance on SEC Release No. 34-39538.

The amendment is signed by Ashley Grim, Head of Global Fund Administration, with the signature date 03/26/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Travelers Companies executive David Donnay exercised 4,731 stock options and sold the same number of shares. On the same day, he converted options into 4,731 common shares at an exercise price of $126.18 per share, then sold 4,731 shares in open-market transactions at a weighted average price of $308.5191 per share.

After these trades, Donnay directly owned 10,478.629 common shares. He also held additional indirect interests, including 5,881.556 shares through a 401(k) plan and 22,083 shares held in trust. The filing notes the sale price is a weighted average across individual trades between $308.18 and $308.62.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

TRAVELERS COMPANIES, INC. executive Maria Olivo exercised stock options for 10,400 shares and then sold 10,400 shares of common stock in an open-market transaction on 2026-02-26. The sale price reflected a weighted average of $306.595 per share across trades in a narrow price range.

Following these transactions, Olivo directly owned 124,742.457 shares of common stock and indirectly held 341.736 shares through a 401(k) plan. The option exercise was reported as a derivative conversion, with the subsequent sale classified as an open-market sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Maria Olivo filed a Form 144 reporting a proposed sale of 10,400 common shares to be sold on 02/26/2026 for cash, from options granted on 02/09/2017. The filing also discloses sales in the prior three months: 8,920 common shares sold on 11/26/2025 for $2,637,911.60 and 10,400 common shares sold on 02/06/2026 for $3,127,832.24.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

How many Travelers Compan (TRV) SEC filings are available on StockTitan?

StockTitan tracks 124 SEC filings for Travelers Compan (TRV), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Travelers Compan (TRV)?

The most recent SEC filing for Travelers Compan (TRV) was filed on April 16, 2026.